ArticleChinese journal of cancer research = Chung-kuo yen cheng yen chiu2024

Efficacy, safety, and multi-omics analysis of pembrolizumab combined with nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: A single-arm phase 2 study.

Lin Gui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.